<p>/PRNewswire/ -- Agentis Longevity，作为行业领先的最佳长寿医疗和健康公司，今天宣布收购 BioDesign，这是一家位于佛罗里达州的顶级长寿医疗公司，专注于卓越的长寿和健康医疗。BioDesign 由 Jeremy Avner、Jimmy Baker 和 Ian Costello 共同创立，以其基于科学的方法优化长期健康而闻名。</p>
<p>该收购显著扩大了 Agentis Longevity 在长寿和优化领域的影响力，涵盖了坦帕、奥兰多、湖玛丽和墨尔本的多个地点，使其能够提供更深入的诊断能力、扩展的临床服务以及更全面的表现和预防服务生态系统。</p>
<p>凭借 BioDesign 的临床专业知识，Agentis Longevity 将能够在其项目中提供更大的个性化服务，包括代谢健康、激素优化、心血管健康、表现恢复、细胞再生和长期健康延续。</p>
<p>&#34;BioDesign 对个性化、数据驱动护理的承诺与我们作为最值得信赖、最具变革性的长寿护理提供者的使命完美契合，&#34; Agentis Longevity 首席执行官 Jimmy St. Louis 表示。&#34;此次收购增强了我们提供基于科学的高度个性化项目的能力，满足客户的期望。我们共同构建了全国最全面的长寿平台。&#34;</p>
<p>BioDesign 的联合创始人 Jeremy Avner 将以战略临床领导角色加入 Agentis Longevity，推动诊断策略、治疗编程和创新。BioDesign 在坦帕、奥兰多、湖玛丽和墨尔本设有多个地点。</p>
<p>&#34;在 BioDesign，我们一直专注于帮助男性更深入地了解自己的身体，并创建基于精准数据的长寿项目，&#34; BioDesign Men's Clinic 的联合创始人 Jeremy Avner 表示。&#34;与 Agentis Longevity 的合作使我们有机会将这一使命带给更广泛的受众。凭借 Agentis 的全国覆盖和对基于表现的医疗的承诺，我们可以提升个性化护理的标准，帮助更多人优化他们的健康寿命，今天以及未来几十年。&#34;</p>
<p>&#34;从临床角度来看，此次收购使我们能够更好地对齐消费者的利益和需求，提供高质量、安全和创新的医疗服务，&#34; BioDesign 的联合创始人 Jimmy Barker 表示。&#34;通过将我们的先进诊断和治疗模型整合到 Agentis 生态系统中，我们可以提供更精确、医学严谨的护理，支持长期表现、预防和健康寿命延续。&#34;</p>
<p>&#34;这一合作代表了一个强大的机会，可以在保持我们对基于科学的个性化护理承诺的同时，扩大 BioDesign 的模式，&#34; BioDesign 的联合创始人 Ian Costello 表示。&#34;我们与 Agentis Longevity 的共同愿景是基于这样的信念：人们应当获得高质量、安全和创新的医疗服务，以符合他们的目标，而不是一刀切的系统。我们将继续提升全国范围内长寿和表现医学的标准。&#34;</p>
<p>BioDesign 与 Agentis Longevity 的整合将增强以下服务：</p>
<ul>
<li>先进的诊断测试和生物标志物分析</li>
<li>个性化长寿健康项目</li>
<li>激素、代谢和心血管优化</li>
<li>恢复、再生和表现疗法</li>
<li>远程监测和持续生物标志物追踪</li>
<li>全国范围内的礼宾和移动服务</li>
</ul>
<p>此次收购进一步巩固了 Agentis Longevity 作为快速增长的长寿和人类表现领域的领先力量，支持运动员、企业高管、娱乐人士以及致力于过上更强壮、更长久和更健康生活的个人。</p>
<p><strong>关于 Agentis Longevity</strong> Agentis Longevity 是精准健康、表现和长寿医学的领导者。该公司提供基于证据的项目，帮助客户优化健康、延长表现和增强寿命，通过基于科学的个性化护理。Agentis 在长寿领域设定了质量标准，将严格的科学与现实世界的可及性相结合。欲了解更多信息，请访问 www.agentislongevity.com</p>
<p><strong>关于 BioDesign Men's Clinic</strong> BioDesign Men's Clinic 是一家专注于精准医疗的私人诊所，专门提供先进的诊断、表现优化和基于长寿的治疗，服务于男性。由 Jeremy Avner 共同创立，BioDesign 提供基于生物标志物数据、先进测试和基于证据的项目的个性化护理，旨在改善长期活力和整体健康。</p>
<p>来源：Agentis Longevity</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA1Jk5ld3NJdGVtSWQ9Tlk4MDgyOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDUxMDI4UFJfTkVXU19VU1BSX19fX19OWTgwODI4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA1Jk5ld3NJdGVtSWQ9Tlk4MDgyOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDUxMDI4UFJfTkVXU19VU1BSX19fX19OWTgwODI4"/></p>

<p>Agentis Longevity 宣布收购位于佛罗里达的长寿医疗公司 BioDesign。这项收购增强了 Agentis 在个性化长寿和表现医学方面的能力，扩展了其诊断和临床服务。BioDesign 的联合创始人将以领导角色加入 Agentis，共同推进提供基于科学的个性化医疗的使命。此次整合旨在改善客户的健康寿命和表现，巩固 Agentis 在不断增长的长寿领域中的地位</p>

<p>, /PRNewswire/ -- Agentis Longevity, an industry leader in best-in-class longevity healthcare and medicine, today announced the acquisition of BioDesign, a premier, Florida based longevity healthcare company, specializing in premier longevity and wellness healthcare. Co-founded by Jeremy Avner, Jimmy Baker, and Ian Costello, BioDesign has become known for their science-backed approach to optimizing long-term health.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Agentis Longevity，作为行业领先的最佳长寿医疗和健康公司，今天宣布收购 BioDesign，这是一家位于佛罗里达州的顶级长寿医疗公司，专注于卓越的长寿和健康医疗。BioDesign 由 Jeremy Avner、Jimmy Baker 和 Ian Costello 共同创立，以其基于科学的方法优化长期健康而闻名。</p>
</div><p>With locations in Tampa, Orlando, Lake Mary, and Melbourne, Florida this acquisition significantly expands Agentis Longevity's footprint in the longevity and optimization space, enabling deeper diagnostic capabilities, expanded clinical offerings, and a more comprehensive ecosystem of performance and preventative services.</p>
<div class="lb-trans"><p>该收购显著扩大了 Agentis Longevity 在长寿和优化领域的影响力，涵盖了坦帕、奥兰多、湖玛丽和墨尔本的多个地点，使其能够提供更深入的诊断能力、扩展的临床服务以及更全面的表现和预防服务生态系统。</p>
</div><p>With BioDesign's clinical expertise, Agentis Longevity will now deliver even greater personalization across its programs including metabolic health, hormone optimization, cardiovascular health, performance recovery, cellular regeneration, and long-term healthspan extension.</p>
<div class="lb-trans"><p>凭借 BioDesign 的临床专业知识，Agentis Longevity 将能够在其项目中提供更大的个性化服务，包括代谢健康、激素优化、心血管健康、表现恢复、细胞再生和长期健康延续。</p>
</div><p>&#34;BioDesign's commitment to personalized, data-driven care aligns perfectly with our mission to drive the standard as the most trusted, transformative provider of longevity care.,&#34; said Jimmy St. Louis, CEO, Agentis Longevity. &#34;This acquisition strengthens our ability to deliver the science-backed, highly individualized programs our clients expect. Together, we're building the most comprehensive longevity platform in the country.&#34;</p>
<div class="lb-trans"><p>&#34;BioDesign 对个性化、数据驱动护理的承诺与我们作为最值得信赖、最具变革性的长寿护理提供者的使命完美契合，&#34; Agentis Longevity 首席执行官 Jimmy St. Louis 表示。&#34;此次收购增强了我们提供基于科学的高度个性化项目的能力，满足客户的期望。我们共同构建了全国最全面的长寿平台。&#34;</p>
</div><p>BioDesign Co-Founder Jeremy Avner will join Agentis Longevity in a strategic clinical leadership role to advance diagnostic strategy, therapeutic programming, and innovation. BioDesign has locations in Tampa, Orlando, Lake Mary, and Melbourne.</p>
<div class="lb-trans"><p>BioDesign 的联合创始人 Jeremy Avner 将以战略临床领导角色加入 Agentis Longevity，推动诊断策略、治疗编程和创新。BioDesign 在坦帕、奥兰多、湖玛丽和墨尔本设有多个地点。</p>
</div><p>&#34;At BioDesign, our focus has always been to help men understand their bodies at a deeper level and create longevity-focused programs rooted in precision data,&#34; said Jeremy Avner, Co-Founder of BioDesign Men's Clinic. &#34;Partnering with Agentis Longevity gives us the opportunity to bring that mission to a broader audience. With Agentis' national reach and commitment to performance-based medicine, we can elevate the standard of personalized care and help more people optimize their healthspan today and for decades to come.&#34;</p>
<div class="lb-trans"><p>&#34;在 BioDesign，我们一直专注于帮助男性更深入地了解自己的身体，并创建基于精准数据的长寿项目，&#34; BioDesign Men's Clinic 的联合创始人 Jeremy Avner 表示。&#34;与 Agentis Longevity 的合作使我们有机会将这一使命带给更广泛的受众。凭借 Agentis 的全国覆盖和对基于表现的医疗的承诺，我们可以提升个性化护理的标准，帮助更多人优化他们的健康寿命，今天以及未来几十年。&#34;</p>
</div><p>&#34;From a clinical standpoint, this acquisition allows us to better align the interests and needs of consumers with high-quality, safe, and innovative healthcare,&#34; said Jimmy Barker, Co-Founder of BioDesign. &#34;By integrating our advanced diagnostics and therapeutic model into the Agentis ecosystem, we can deliver even more precise, medically rigorous care that supports long-term performance, prevention, and healthspan extension.&#34;</p>
<div class="lb-trans"><p>&#34;从临床角度来看，此次收购使我们能够更好地对齐消费者的利益和需求，提供高质量、安全和创新的医疗服务，&#34; BioDesign 的联合创始人 Jimmy Barker 表示。&#34;通过将我们的先进诊断和治疗模型整合到 Agentis 生态系统中，我们可以提供更精确、医学严谨的护理，支持长期表现、预防和健康寿命延续。&#34;</p>
</div><p>&#34;This partnership represents a powerful opportunity to scale the BioDesign model while preserving our commitment to science-backed, individualized care,&#34; said Ian Costello, Co-Founder of BioDesign. &#34;Our shared vision with Agentis Longevity is centered on the belief that people deserve access to high-quality, safe, and innovative healthcare that aligns with their goals not a one-size-fits-all system. Together, we will continue elevating the standard for longevity and performance medicine nationwide.&#34;</p>
<div class="lb-trans"><p>&#34;这一合作代表了一个强大的机会，可以在保持我们对基于科学的个性化护理承诺的同时，扩大 BioDesign 的模式，&#34; BioDesign 的联合创始人 Ian Costello 表示。&#34;我们与 Agentis Longevity 的共同愿景是基于这样的信念：人们应当获得高质量、安全和创新的医疗服务，以符合他们的目标，而不是一刀切的系统。我们将继续提升全国范围内长寿和表现医学的标准。&#34;</p>
</div><p>The integration of BioDesign into Agentis Longevity will enhance offerings across:</p>
<div class="lb-trans"><p>BioDesign 与 Agentis Longevity 的整合将增强以下服务：</p>
</div><ul>
<li>Advanced diagnostic testing &amp; biomarker analysis</li>
<li>Personalized longevity health programs</li>
<li>Hormone, metabolic, and cardiovascular optimization</li>
<li>Recovery, regeneration, and performance therapies</li>
<li>Remote monitoring and continuous biomarker tracking</li>
<li>Concierge and mobile services nationwide</li>
</ul>
<div class="lb-trans"><ul>
<li>先进的诊断测试和生物标志物分析</li>
<li>个性化长寿健康项目</li>
<li>激素、代谢和心血管优化</li>
<li>恢复、再生和表现疗法</li>
<li>远程监测和持续生物标志物追踪</li>
<li>全国范围内的礼宾和移动服务</li>
</ul>
</div><p>This acquisition further solidifies Agentis Longevity as a leading force in the rapidly growing longevity and human performance sector, supporting athletes, executives, entertainers, and individuals committed to living stronger, longer, and healthier lives.</p>
<div class="lb-trans"><p>此次收购进一步巩固了 Agentis Longevity 作为快速增长的长寿和人类表现领域的领先力量，支持运动员、企业高管、娱乐人士以及致力于过上更强壮、更长久和更健康生活的个人。</p>
</div><p><strong>About Agentis Longevity</strong> Agentis Longevity is a leader in precision-based health, performance, and longevity medicine. The company provides evidence-driven programs that empower clients to optimize health, extend performance, and enhance lifespan through science-backed, individualized care. Agentis sets the quality standard in longevity bridging rigorous science with real-world accessibility. For more information please visit www.agentislongevity.com</p>
<div class="lb-trans"><p><strong>关于 Agentis Longevity</strong> Agentis Longevity 是精准健康、表现和长寿医学的领导者。该公司提供基于证据的项目，帮助客户优化健康、延长表现和增强寿命，通过基于科学的个性化护理。Agentis 在长寿领域设定了质量标准，将严格的科学与现实世界的可及性相结合。欲了解更多信息，请访问 www.agentislongevity.com</p>
</div><p><strong>ABOUT BIODESIGN MEN'S CLINIC</strong> BioDesign Men's Clinic is a precision-focused private practice specializing in advanced diagnostics, performance optimization, and longevity-based therapies for men. Co-founded by Jeremy Avner, BioDesign delivers individualized care rooted in biomarker data, advanced testing, and evidence-based programs designed to improve long-term vitality and overall health.</p>
<div class="lb-trans"><p><strong>关于 BioDesign Men's Clinic</strong> BioDesign Men's Clinic 是一家专注于精准医疗的私人诊所，专门提供先进的诊断、表现优化和基于长寿的治疗，服务于男性。由 Jeremy Avner 共同创立，BioDesign 提供基于生物标志物数据、先进测试和基于证据的项目的个性化护理，旨在改善长期活力和整体健康。</p>
</div><p>SOURCE Agentis Longevity</p>
<div class="lb-trans"><p>来源：Agentis Longevity</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA1Jk5ld3NJdGVtSWQ9Tlk4MDgyOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDUxMDI4UFJfTkVXU19VU1BSX19fX19OWTgwODI4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY80828&amp;Transmission_Id=202602051028PR_NEWS_USPR_____NY80828&amp;DateId=20260205"/></p>

10:28 ETAgentis Longevity Announces Acquisition of BioDesign, Expanding Its Leadership in Personalized Longevity, Performance Medicine & Advanced Health Optimization

prnewswire

Invesco Nasdaq Biotechnology ETF

生物科技 ETF - VanEck Vectors

基因免疫&健康关怀 ETF - iShares

美国医疗保健供应商 ETF - iShares

动态生物技术与基因组 ETF - Invesco

Longevity Health

基因改革 ETF - ARK

LONGEVITY HEALTH HLDGS INC C/WTS 12/07/2028 (TO PUR COM)

美国医药设备 ETF - iShares

医药突破 ETF - ALPS

标普健康医疗设备 ETF - SPDR

标普生物技术 ETF - SPDR

2 倍做多纳斯达克生物技术 ETF - ProShares

纳斯达克生物科技指数 ETF - iShares Nasdaq

LifeX 2050 Longevity Income ETF

医疗业 ETF - SPDR

LifeX 2061 Longevity Income ETF

纽交所高增长板生物技术指数 ETF - First Trust

10:28 ETAgentis Longevity 宣布收购 BioDesign，进一步扩大其在个性化长寿、性能医学和先进健康优化领域的领导地位